STOCK TITAN

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and operating results after the market close on Wednesday, February 25, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

To participate in the conference call by telephone, dial 1-800-343-4136 or 1-203-518-9843 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.

Deb Hart

Maravai LifeSciences

+ 1 858-988-5917

ir@maravai.com

Source: Maravai LifeSciences, Inc.

Maravai Lifesciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Latest SEC Filings

MRVI Stock Data

455.37M
106.39M
10.16%
90.18%
9.59%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO